Polyvascular Disease | Zendy

J. Antonio Gutierrez | Zendy; Aaron W. Aday | Zendy; Manesh R. Patel | Zendy; W. Schuyler Jones | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Polyvascular Disease

Author(s) -

J. Antonio Gutierrez,

Aaron W. Aday,

Manesh R. Patel,

W. Schuyler Jones

Publication year - 2019

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.119.007385

Subject(s) - medicine , antithrombotic , disease , observational study , intensive care medicine , atherosclerotic cardiovascular disease , clinical trial , cardiology

Atherosclerosis within 2 or more arterial beds has been termed polyvascular disease. Although polyvascular disease has long been associated with heightened cardiovascular risk, much is still unknown regarding its pathophysiology and management. In this past decade, the field of cardiovascular disease has experienced exponential growth in terms of antithrombotic and lipid-lowering therapies aimed at mitigating ischemic events. This review describes the inherent risk associated with polyvascular disease in contemporary observational and clinical trial populations and summarizes novel therapies in this high-risk population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research